Realistic close-up of basal cell carcinoma on the side of the nose, showing a small pink raised lesion with a central crusted area.

What Is Basal Cell Carcinoma? Warning Signs, Risk Factors & Treatment Options

What Is Basal Cell Carcinoma? Warning Signs, Risk Factors & Treatment Options

Basal cell carcinoma is a type of skin cancer that often grows slowly but can invade nearby skin and tissue if it is not diagnosed and treated. It is often shortened to BCC.

This page explains warning signs, common locations, risk factors, diagnosis, biopsy, treatment options, follow-up, prevention, mistakes, and when to seek care. BCC can look like a pimple, sore, scaly patch, scar, shiny bump, or pigmented lesion, so persistent or changing spots need professional evaluation.

What Is Basal Cell Carcinoma and How Does It Start?

Basal cell carcinoma is a type of skin cancer that begins in basal cells of the epidermis and often develops after ultraviolet light damages skin-cell DNA.

The epidermis is the outer skin layer. Basal cells sit near the bottom of that layer and help produce new skin cells. When DNA damage and growth-control errors accumulate, abnormal keratinocyte growth can create a persistent cancerous lesion.

BCC is a keratinocyte cancer and a nonmelanoma skin cancer. It is often slow-growing, but it is still cancer and should not be treated as a cosmetic mark.

Why Is Basal Cell Carcinoma Common but Still Serious?

Basal cell carcinoma is common and often slow-growing, but it is still serious because untreated tumors can grow deeper and damage nearby skin, cartilage, nerves, or other tissue.

BCC rarely spreads to distant body parts compared with some other cancers, but “rarely spreads” does not mean safe to ignore. Local invasion can create scarring, disfigurement, tissue loss, and complicated treatment, especially on the nose, eyelids, ears, lips, scalp, hands, and genitals.

Early diagnosis usually makes treatment simpler. Delayed care can make the final repair larger than the visible spot first suggested.

Why Is Basal Cell Carcinoma Not Just Sun Damage?

Basal cell carcinoma is not just sun damage because the lesion already contains cancer cells that require diagnosis and treatment, not sunscreen alone.

UV exposure increases future risk and can damage skin-cell DNA over years. Once a sore bleeds, crusts, heals, and returns, or a shiny bump, scaly patch, scar-like area, or pigmented lesion persists, the priority is evaluation and biopsy when suspicious.

Sun protection helps reduce future UV damage. It does not remove, destroy, or control an existing BCC.

Scientific illustration of ultraviolet damage leading to basal cell carcinoma A scientific process graphic showing ultraviolet exposure, DNA damage in basal keratinocyte cells, abnormal growth, persistent lesion, and local invasion risk. UV Damage to Persistent BCC Lesion UV exposure sun + tanning beds DNA damage basal cells Abnormal cell growth BCC lesion Local invasion risk untreated BCC can grow into nearby skin, cartilage, nerves, or other tissue Sunscreen reduces future UV damage but does not treat an existing cancer. Scientific illustration: persistent lesions need biopsy-based evaluation, not home treatment. skinkeeps.com
Figure 1. Basal cell carcinoma can begin after UV-related DNA damage changes basal or keratinocyte growth, creating a persistent lesion with local invasion risk.

Practical rule: A spot that bleeds, crusts, heals, returns, or keeps growing should not be treated for months as a pimple, scratch, eczema patch, or dry area.

What Basal Cell Carcinoma Warning Signs Can Appear on Skin?

Basal cell carcinoma warning signs can include a shiny or pearly bump, non-healing sore, bleeding or crusting spot, flat scaly patch, scar-like area, pink or red growth, or darker pigmented lesion.

BCC does not have one single look. It can be skin-colored, pink, red, brown, black, blue, gray, glossy, waxy, scaly, or scar-like depending on subtype, body site, skin tone, and how long it has been present.

What Does Nodular Basal Cell Carcinoma Look Like?

Nodular basal cell carcinoma often looks like a shiny, pearly, translucent, skin-colored, pink, red, brown, or darker bump that may bleed, crust, or develop a central ulcer.

Tiny visible blood vessels may appear on the surface. The bump may have a rolled border or a central depression. It commonly appears on the face, head, or neck.

In brown and Black skin, BCC may appear brown, darker, or glossy black rather than pink or pearly, so color alone should never reassure the reader.

What Does Superficial Basal Cell Carcinoma Look Like?

Superficial basal cell carcinoma can look like a flat pink, red, brown, or scaly patch that grows slowly and may be mistaken for eczema, psoriasis, or irritation.

This pattern may appear on the trunk, shoulders, arms, or legs. A single scaly patch that keeps returning, bleeding, crusting, or failing routine treatment deserves evaluation instead of repeated steroid or moisturizer use.

What Does Morpheaform or Scar-Like Basal Cell Carcinoma Look Like?

Morpheaform basal cell carcinoma can look like a waxy, pale, firm, scar-like area with poorly defined borders, sometimes without a history of injury.

Because the edges may be hard to see, treatment planning can be more careful than the surface mark suggests. A scar-like patch that appears without a clear injury or keeps enlarging should not be dismissed.

What Does Pigmented Basal Cell Carcinoma Look Like?

Pigmented basal cell carcinoma can look brown, black, blue, gray, or glossy darker, which means it can be confused with melanoma, mole changes, or seborrheic keratosis.

Dermoscopy and biopsy may be needed because pigment does not tell the full diagnosis. A dark changing lesion, a glossy black bump, or a pigmented lesion with bleeding, crusting, or a rolled border should be checked promptly.

Scientific graphic of basal cell carcinoma appearance patterns A scientific warning-sign graphic showing nodular pearly bump, superficial scaly patch, scar-like morpheaform patch, and pigmented basal cell carcinoma pattern. BCC Appearance Patterns Need Biopsy-Based Evaluation Nodular pattern pearly, shiny, bleeding bump tiny vessels or central ulcer Superficial pattern flat scaly patch can mimic rash Scar-like pattern waxy, firm, ill-defined no injury history Pigmented pattern brown, black, blue, gray can mimic melanoma Pattern recognition helps urgency, but biopsy confirms the diagnosis. Scientific graphic: BCC can be bump-like, scaly, scar-like, or pigmented. skinkeeps.com
Figure 2. Basal cell carcinoma can appear as a pearly bump, scaly patch, scar-like area, or pigmented lesion, so persistent changes need professional assessment.
BCC SignWhat It May Look LikeWhy It Matters
Pearly bumpShiny, translucent, skin-colored, pink, brown, or glossy black bumpClassic nodular clue
Non-healing soreSore that persists or returnsNeeds evaluation
Bleeding/crusting spotScabs, bleeds, heals, then returnsCommon delay pattern
Visible vesselsTiny surface blood vesselsSupports BCC suspicion
Scaly patchFlat pink, red, brown, or darker patchCan mimic eczema or psoriasis
Scar-like areaWaxy, firm, pale, ill-defined patchCan hide deeper spread
Pigmented lesionBrown, black, blue, gray, or darker lesionCan mimic melanoma or benign growths

Where Does Basal Cell Carcinoma Usually Appear?

Basal cell carcinoma most often appears on sun-exposed areas such as the face, nose, ears, scalp, neck, shoulders, arms, and hands, but it can also occur in less sun-exposed areas.

Common sites include the nose, eyelids, cheeks, ears, lips or skin around the mouth, scalp, neck, shoulders, chest, back, arms, and hands. BCC on a thinning or bald scalp can be harder to see during routine self-checks.

Protected areas such as the genitals are less common sites, but a non-healing sore or changing growth should not be dismissed because it is not sun-exposed. Location matters because treatment must preserve function, tissue, and appearance whenever possible.

LocationCommon Warning SignTreatment-Planning Concern
NosePearly bump, bleeding sore, ulcerTissue-sparing and cosmetic/function risk
EyelidShiny bump, crusting, non-healing lesionEye protection and specialist planning
EarCrusting, sore, scaly or bleeding spotCartilage and recurrence risk
Lip / around mouthPersistent sore or shiny growthFunction and cosmetic planning
ScalpBleeding or crusting spot, especially on thinning scalpHarder self-monitoring
Neck / shouldersScaly patch or pearly bumpSun-exposed distribution
TrunkSuperficial scaly patchCan mimic eczema or psoriasis
Hands / armsNon-healing sun-damaged lesionFunctional area and sun exposure
Protected areasUnusual sore or growthDo not dismiss because it is not sun-exposed

What Risk Factors Increase Basal Cell Carcinoma Risk?

Basal cell carcinoma risk increases with ultraviolet exposure, tanning beds, sunburn history, fair complexion traits, older age, prior skin cancer, immune suppression, radiation exposure, arsenic exposure, and certain inherited syndromes.

Risk factors help decide who needs a lower threshold for checking lesions. They do not mean people without obvious risk factors can ignore a suspicious spot.

How Does UV Exposure Increase Basal Cell Carcinoma Risk?

Ultraviolet exposure increases basal cell carcinoma risk by damaging skin-cell DNA over time, especially with chronic sun exposure, intense intermittent exposure, sunburns, and tanning beds.

Outdoor work, outdoor recreation, high-UV environments, and tanning lamps can increase cumulative damage. UV damage may build for years before a visible lesion appears.

Which Personal Factors Can Increase Basal Cell Carcinoma Risk?

Personal factors that can increase basal cell carcinoma risk include fair skin that burns easily, light-colored eyes, blond or red hair, freckles, older age, prior BCC, and personal or family history of skin cancer.

Darker skin tones have lower incidence, but BCC can still occur and may be diagnosed later if suspicious spots are dismissed. Prior BCC also raises the need to watch for new primary tumors over time.

Which Medical or Environmental Factors Increase Basal Cell Carcinoma Risk?

Medical and environmental BCC risk factors include immune suppression, organ transplant history, prior radiation therapy, arsenic exposure, and inherited syndromes that increase skin-cancer susceptibility.

Basal cell nevus syndrome, also called Gorlin syndrome, and xeroderma pigmentosum can increase risk of multiple or early skin cancers. These are specialist-surveillance situations, not routine sunspot situations.

Risk FactorWhy It MattersPrevention / Evaluation Action
Chronic UV exposureAccumulated DNA damageSun protection and skin checks
Tanning bedsArtificial UV exposureAvoid tanning beds
Sunburn historyMarker of UV injuryWatch damaged areas
Fair complexion traitsHigher UV sensitivityLower threshold for checking spots
Darker skin tonesLower incidence but possible delayed diagnosisDo not dismiss suspicious lesions
Prior BCCNew primary tumors can occurFollow-up exams
Immune suppressionHigher skin-cancer riskEarlier specialist review
Radiation / arsenicEnvironmental carcinogen contextShare exposure history
Inherited syndromesMultiple or early tumors possibleSpecialist surveillance

How Is Basal Cell Carcinoma Different From Other Skin Spots?

Basal cell carcinoma can mimic pimples, eczema, psoriasis, scars, moles, seborrheic keratoses, squamous cell carcinoma, or melanoma, so persistent or changing lesions should be checked rather than treated as routine irritation.

Behavior matters. A short-lived bump that resolves is different from a lesion that bleeds, crusts, heals, returns, grows, ulcerates, or resists routine care.

How Is Basal Cell Carcinoma Different From Acne or a Pimple?

Basal cell carcinoma is different from acne because pimples usually improve, while BCC may persist, bleed, crust, ulcerate, or return in the same spot.

A “pimple” on the nose, cheek, eyelid, ear, lip area, or scalp that does not heal after weeks or keeps bleeding should be checked. Not every face bump is BCC, but persistence changes the safety level.

How Is Basal Cell Carcinoma Different From Eczema or Psoriasis?

Basal cell carcinoma can look like eczema or psoriasis when it appears as a persistent scaly patch, but a single patch that does not respond or keeps recurring should be checked.

Superficial BCC can look rash-like. Atopic dermatitis and psoriasis often have broader, recurring inflammatory patterns, while a single stubborn scaly patch may need biopsy consideration.

How Is Basal Cell Carcinoma Different From Melanoma or Squamous Cell Carcinoma?

Basal cell carcinoma is different from melanoma and squamous cell carcinoma, but pigmented BCC and crusted or scaly BCC can overlap visually, so biopsy is the deciding step when a lesion is suspicious.

Melanoma often raises concern through changing pigment, asymmetry, border irregularity, multiple colors, or evolution. Squamous cell carcinoma may look thicker, scaly, crusted, tender, painful, or faster-growing. A clinician should decide when biopsy is needed.

How Is Basal Cell Carcinoma Different From Actinic Keratosis or Seborrheic Keratosis?

Basal cell carcinoma is different from actinic keratosis and seborrheic keratosis because BCC is already skin cancer, while those lesions have different risk and treatment pathways.

Actinic keratosis is a sun-damaged precancer-type lesion mainly tied to the squamous-cell pathway. Seborrheic keratosis is usually a benign waxy or stuck-on growth, but pigmented or irritated lesions may still need dermoscopy or biopsy if uncertain.

ConditionCommon ClueWhy Confusion HappensBest Next Step
BCCPearly bump, non-healing sore, bleeding/crusting, scar-like or scaly patchMany appearancesDermatology exam and biopsy if suspicious
AcnePimple improves or changes over timeFace bumps overlapCheck persistent non-healing bumps
Eczema / psoriasisItchy or scaly inflammatory plaquesSuperficial BCC can look rash-likeCheck single persistent patch
Actinic keratosisRough sun-damaged scaly spotUV-damaged skin context overlapsDermatology evaluation if persistent/changing
Seborrheic keratosisWaxy “stuck-on” growthPigmented BCC may mimic benign growthDermoscopy/biopsy if uncertain
SCCScaly, crusted, tender, growing lesionBoth are keratinocyte cancersBiopsy suspicious lesion
MelanomaChanging pigmented lesionPigmented BCC can look darkPrompt evaluation if changing/pigmented

How Is Basal Cell Carcinoma Diagnosed or Checked?

Basal cell carcinoma is usually diagnosed by skin examination and biopsy, where a sample of the suspicious lesion is examined to confirm the cancer type and guide treatment.

Photos can help show change over time, but photo appearance alone should not be the diagnostic standard. A dermatologist may use close inspection, dermoscopy, and biopsy when the lesion is suspicious.

What Does a Dermatologist Check With Suspected Basal Cell Carcinoma?

A dermatologist checks a suspected basal cell carcinoma by reviewing lesion size, location, borders, color, bleeding, crusting, ulceration, tiny blood vessels, scar-like texture, and growth history.

Prior skin cancer history, immune suppression, transplant history, radiation exposure, and high-risk locations also matter. High-risk sites include the eyelid, nose, ear, lip, scalp, hand, genital area, and other functionally or cosmetically sensitive sites.

Why Does Biopsy Matter Before Basal Cell Carcinoma Treatment?

Biopsy matters before basal cell carcinoma treatment because it confirms whether the lesion is cancer, identifies key subtype clues, and helps choose the safest treatment.

Biopsy can help separate BCC from melanoma, squamous cell carcinoma, infection, scar tissue, and benign growths. It also helps guide excision, Mohs surgery, topical treatment, radiation, or advanced treatment decisions.

Suspicious lesions should not be frozen, burned, scraped, bleached, or treated with long-term steroid cream at home before diagnosis.

  • Suspicious lesion is examined.
  • Dermoscopy may be used when helpful.
  • Biopsy samples the lesion.
  • Histology confirms the cancer type.
  • Subtype and risk clues are reviewed.
  • Size, depth, location, borders, recurrence, and patient factors guide treatment.

What Treatment Options Are Used for Basal Cell Carcinoma?

Basal cell carcinoma treatment depends on tumor size, depth, subtype, location, borders, recurrence status, patient health, and cosmetic or functional risk.

The goal is to remove, destroy, or control the cancer cells while preserving healthy tissue and function as much as possible. Treatment should be chosen after diagnosis and risk assessment.

When Is Surgical Excision Used for Basal Cell Carcinoma?

Surgical excision is commonly used for many basal cell carcinomas because it removes the tumor with a margin of normal-looking skin that can be checked by pathology.

Excision may be suitable for many low-risk or well-defined lesions. Pathology review helps assess whether margins are clear. Scar planning and repair choice depend on location and size.

When Is Mohs Surgery Used for Basal Cell Carcinoma?

Mohs surgery is often considered for basal cell carcinoma in high-risk locations, recurrent tumors, aggressive subtypes, poorly defined borders, or areas where saving healthy tissue is especially important.

Mohs checks tissue layer by layer while preserving as much normal tissue as possible. It may be especially useful on the nose, eyelids, ears, lips, face, hands, genitals, and other sensitive sites. Not every BCC needs Mohs.

When Are Curettage, Electrodesiccation, Cryotherapy, or Topical Treatments Used?

Curettage, electrodesiccation, cryotherapy, or topical treatments may be used only for selected low-risk BCCs when the tumor type, depth, location, and patient factors make them appropriate.

Topical imiquimod or topical 5-fluorouracil may be considered mainly for selected superficial BCCs under dermatologist guidance. These are not appropriate for deep, aggressive, recurrent, high-risk, or unclear lesions.

Nonsurgical approaches can have lower cure rates than surgery, so selection matters.

When Are Radiation or Advanced Systemic Treatments Considered?

Radiation or advanced systemic treatments may be considered when surgery is not suitable, disease is complex, cancer remains after surgery, or BCC is locally advanced or metastatic.

Hedgehog pathway inhibitors such as vismodegib or sonidegib may be used in selected advanced cases. Immunotherapy such as cemiplimab may be considered in selected advanced settings. These are specialist-led options, not routine treatment for ordinary small BCCs.

Scientific diagnosis and treatment pathway for basal cell carcinoma A scientific pathway showing suspicious lesion, skin exam, biopsy, histology, risk assessment, excision, Mohs surgery, selected nonsurgical treatment, follow-up, and sun protection. Biopsy-Based Diagnosis and Risk-Matched Treatment Suspicious lesion persistent or changing Skin exam dermoscopy if useful Biopsy histology confirms Risk review site, subtype, margins Treatment excision, Mohs, selected care Follow-up scar + new lesions Treatment choice depends on cancer risk, not appearance alone. Scientific graphic: biopsy confirms BCC and guides risk-matched treatment planning. skinkeeps.com
Figure 3. Basal cell carcinoma care starts with suspicious-lesion evaluation and biopsy, then treatment is matched to size, site, subtype, borders, recurrence, and patient factors.
BCC Type / RiskLikely Treatment DirectionGoalKey Caution
Low-risk, well-defined BCCSurgical excision or selected local treatmentRemove or destroy cancer cellsMust be confirmed and risk-assessed
Facial/high-risk locationMohs or tissue-sparing specialist planClear margins while preserving function/cosmesisNot every face lesion automatically gets same treatment
Superficial low-risk BCCSelected topical, destructive, or surgical optionsTreat superficial cancerNot for deep or aggressive lesions
Recurrent BCCMohs or specialist-led treatmentReduce recurrence riskPrior treatment changes planning
Aggressive/ill-defined subtypeMohs or surgery specialist planningDefine and clear marginsBorders may extend beyond visible lesion
Surgery not suitableRadiation or nonsurgical treatment in selected casesControl cancer when surgery unsuitableCure rates and side effects differ
Locally advanced/metastatic BCCHedgehog inhibitor, immunotherapy, oncology-led planShrink or control advanced diseaseSpecialist monitoring required

How Does Basal Cell Carcinoma Follow-Up Reduce Recurrence Risk?

Follow-up after basal cell carcinoma matters because a person who has had one BCC can develop recurrence at a treated site or another primary skin cancer later.

Follow-up checks the scar, surrounding skin, and other sun-damaged areas. The schedule depends on tumor risk, treatment type, margins, prior skin cancer history, immune status, and dermatologist advice.

AAD guideline highlights recommend annual checks after BCC diagnosis for recurrence or another new primary skin cancer. Some people need more frequent checks based on risk.

How Can Sun Protection Lower Future Basal Cell Carcinoma Risk?

Sun protection cannot treat an existing basal cell carcinoma, but it can reduce additional ultraviolet damage and help lower future sun-related skin-cancer risk.

Use shade, protective clothing, a wide-brim hat, UV-protective sunglasses, and broad-spectrum sunscreen on exposed skin. Reapply sunscreen during outdoor exposure according to the product label and activity level.

Pay attention to ears, nose, lips, scalp, neck, and hands because these areas receive frequent UV exposure. Avoid tanning beds and tanning lamps completely, especially after a prior BCC.

  • Seek shade when UV is strong.
  • Wear protective clothing and a wide-brim hat.
  • Protect ears, nose, lips, scalp, neck, and hands.
  • Use broad-spectrum sunscreen on exposed skin.
  • Reapply sunscreen during outdoor exposure.
  • Avoid tanning beds and tanning lamps.
  • Check previously treated areas and new sun-exposed spots.
  • Keep dermatologist follow-up after BCC treatment.

What Basal Cell Carcinoma Mistakes Should You Avoid?

The biggest basal cell carcinoma mistake is repeatedly treating a non-healing, bleeding, crusting, pearly, or scar-like skin spot as acne, eczema, a scratch, or dry skin without getting it checked.

Do not pick, scrape, burn, freeze, bleach, or try to remove a suspicious lesion at home. Do not assume a painless lesion is safe. Do not continue steroid cream for months on a single persistent scaly patch without diagnosis.

Delaying evaluation is especially risky for lesions near the eyes, nose, ears, lips, scalp, hands, genitals, or other sites where tissue preservation matters.

MistakeWhy It Is RiskyBetter Action
Calling it a pimple for monthsBCC can mimic acneCheck non-healing bumps
Moisturizer-only careA cancer lesion will not be cured by moisturizerSeek evaluation for persistent sores
Repeated steroid useMay delay diagnosis of a single persistent patchBiopsy suspicious lesions
Ignoring bleeding/crustingCommon warning patternDermatology review
DIY freezing/burningMay miss cancer margins and delay careGet diagnosis first
Ignoring high-risk sitesNose, eyelids, ears, lips, hands, genitals need careful planningPrompt specialist review
Skipping follow-upNew BCCs or recurrence can occurSchedule skin checks

When Should Basal Cell Carcinoma Be Checked Promptly?

A skin spot should be checked promptly when it does not heal, bleeds, crusts, grows, forms an ulcer, looks pearly or shiny, develops visible blood vessels, resembles a scar without injury, or changes over time.

A suspicious spot should not be watched for months when it repeatedly scabs, bleeds, returns, grows, or sits on a high-risk area.

Which Basal Cell Carcinoma Warning Signs Need Faster Evaluation?

Faster evaluation is needed for a non-healing sore, recurring scab, recurrent bleeding, pearly or shiny bump, scar-like patch, pigmented changing lesion, or suspicious spot near a high-risk location.

High-risk locations include the eye area, nose, ear, lip, scalp, hand, foot, genital area, and sites where function or appearance could be affected. Immunosuppressed people should have a lower threshold for evaluation.

What Should You Bring to a Basal Cell Carcinoma Appointment?

A helpful basal cell carcinoma appointment starts with photos, timeline, bleeding or crusting history, growth changes, sun exposure history, prior skin cancer history, immune status, medicines, and treatments already tried.

Bring the date the spot first appeared, whether it hurts or itches, whether it heals and returns, and whether it affects eyelid movement, nose shape, lip movement, hand function, or another sensitive site.

Seek prompt care for a spot that is:

What Should You Remember About Basal Cell Carcinoma?

The most important thing to remember about basal cell carcinoma is that it is usually treatable, but it is still skin cancer and needs biopsy-based diagnosis, appropriate treatment, and follow-up.

Slow growth should not create delay. Persistent warning signs, sensitive locations, pigmented changes, bleeding, crusting, ulceration, and treatment-resistant patches should be checked.

Frequently Asked Questions About Basal Cell Carcinoma

Is basal cell carcinoma cancer?

Yes. Basal cell carcinoma is a type of skin cancer. It often grows slowly and rarely spreads, but it can grow deeper and damage nearby tissue if untreated.

What does basal cell carcinoma look like?

Basal cell carcinoma can look like pearly or shiny bumps, non-healing sores, bleeding or crusting spots, flat scaly patches, scar-like areas, visible blood vessels, and pigmented lesions.

Does basal cell carcinoma spread?

BCC rarely spreads to distant body parts compared with many other cancers, but it can grow locally and damage nearby tissue if untreated.

What causes basal cell carcinoma?

Risk is linked with UV exposure from sunlight or tanning beds, DNA damage, fair complexion traits, sunburn history, age, prior skin cancer, immune suppression, radiation exposure, arsenic exposure, and inherited syndromes.

How is basal cell carcinoma diagnosed?

Basal cell carcinoma is diagnosed with skin examination, dermoscopy when useful, and biopsy to confirm the cancer type and guide treatment.

What is the best treatment for basal cell carcinoma?

There is no one best treatment for every BCC. Treatment depends on tumor size, depth, subtype, location, borders, recurrence status, patient health, and cosmetic or functional risk.

When is Mohs surgery used for basal cell carcinoma?

Mohs surgery is often used for high-risk locations, recurrent tumors, aggressive or poorly defined subtypes, and areas where tissue preservation is important, such as the nose, eyelids, ears, lips, face, hands, or genitals.

Can topical creams treat basal cell carcinoma?

Some topical medicines may be used for selected superficial, low-risk BCCs under dermatologist guidance, but they are not appropriate for all BCCs and should not replace biopsy-based diagnosis.

When should a suspicious spot be checked?

A suspicious spot should be checked when it is non-healing, repeatedly bleeding or crusting, pearly, shiny, scar-like, changing, pigmented, in a high-risk location, treatment-resistant, or occurring in an immunosuppressed person.

Sources & Evidence About Basal Cell Carcinoma

American Academy of Dermatology — Basal Cell Carcinoma was used for definition, slow growth and rare spread balanced with deep-growth warning, common symptoms, diagnosis, excision, Mohs surgery, cryosurgery, radiation, advanced medicines, and early-treatment framing.

American Academy of Dermatology — Basal Cell Carcinoma Clinical Guideline was used for risk stratification, optimal biopsy principles, surgery as the cornerstone of treatment, nonsurgical lower-cure-rate caution, early complete treatment, and annual checks after BCC diagnosis.

DermNet — Basal Cell Carcinoma was used for BCC as common locally invasive keratinocyte cancer, most common skin cancer framing, subtypes, multiple primary tumors, pigmented and nonpigmented presentations, risk factors, treatment categories, and follow-up.

Mayo Clinic — Basal Cell Carcinoma Symptoms and Causes was used for sun-exposed locations, head and neck tendency, protected-site possibility, skin-tone variation, lesion types, sore that does not heal, UV/DNA explanation, and rare spread with local invasion risk.

Mayo Clinic — Basal Cell Carcinoma Diagnosis and Treatment was used for skin biopsy, biopsy sample testing, treatment depending on type, location, size, recurrence, follow-up ability, and surgery-first treatment framing.

National Cancer Institute — Skin Cancer Treatment PDQ was used for BCC and SCC as common nonmelanoma skin cancers, BCC burden context, skin-cancer signs, risk factors, and treatment category framing.

StatPearls / NCBI Bookshelf — Basal Cell Carcinoma was used for chronic UV exposure as a principal risk factor, DNA damage, hedgehog-pathway context, rare metastasis, local tissue destruction and disfigurement warning, and the broad management range.

Educational Disclaimer: This SkinKeeps article is for educational purposes only and does not diagnose or replace medical care. A non-healing, bleeding, crusting, ulcerated, pearly, shiny, scar-like, pigmented, changing, painful, high-risk-location, or treatment-resistant skin spot should be checked by a qualified healthcare professional or dermatologist.

Beautiful Newsletter Form

Subscribe to the Newsletter

We send out research-backed guides every two weeks. Unsubscribe at any time.

Related ARTICLES